Maximus (NYSE:MMS) Downgraded by Zacks Research to “Strong Sell”

Maximus (NYSE:MMS) was downgraded by equities research analysts at Zacks Research from a “hold” rating to a “strong sell” rating in a report issued on Tuesday,Zacks.com reports.

Several other equities research analysts have also weighed in on MMS. Wall Street Zen lowered Maximus from a “buy” rating to a “hold” rating in a research report on Saturday, August 8th. Weiss Ratings downgraded shares of Maximus from a “hold (c)” rating to a “hold (c-)” rating in a report on Wednesday, May 20th. One equities research analyst has rated the stock with a Hold rating and one has given a Sell rating to the stock. Based on data from MarketBeat, the company has an average rating of “Reduce”.

Maximus Price Performance

MMS opened at $54.45 on Tuesday. The company has a fifty day simple moving average of $58.24 and a 200 day simple moving average of $66.33. The firm has a market cap of $2.85 billion, a price-to-earnings ratio of 8.04 and a beta of 0.59. Maximus has a twelve month low of $52.73 and a twelve month high of $100.00. The company has a current ratio of 2.42, a quick ratio of 2.42 and a debt-to-equity ratio of 0.90.

Maximus (NYSE:MMS) last issued its quarterly earnings data on Thursday, August 6th. The health services provider reported $2.22 EPS for the quarter, topping analysts’ consensus estimates of $2.21 by $0.01. The firm had revenue of $1.28 billion for the quarter, compared to analyst estimates of $1.33 billion. Maximus had a net margin of 7.07% and a return on equity of 24.91%. The firm’s revenue was down 5.1% compared to the same quarter last year. During the same quarter in the previous year, the business posted $2.16 EPS. Maximus has set its FY 2026 guidance at 7.900-8.200 EPS. Equities research analysts expect that Maximus will post 8.01 EPS for the current fiscal year.

Hedge Funds Weigh In On Maximus

A number of hedge funds and other institutional investors have recently modified their holdings of the stock. Farther Finance Advisors LLC raised its holdings in Maximus by 69.0% during the 4th quarter. Farther Finance Advisors LLC now owns 284 shares of the health services provider’s stock worth $25,000 after buying an additional 116 shares during the period. Advisory Services Network LLC acquired a new position in shares of Maximus in the third quarter worth about $32,000. Canada Pension Plan Investment Board acquired a new position in shares of Maximus in the second quarter worth about $35,000. Northwestern Mutual Wealth Management Co. boosted its holdings in shares of Maximus by 225.2% in the fourth quarter. Northwestern Mutual Wealth Management Co. now owns 439 shares of the health services provider’s stock worth $38,000 after buying an additional 304 shares during the period. Finally, Global Retirement Partners LLC acquired a new stake in shares of Maximus during the second quarter valued at approximately $40,000. Institutional investors and hedge funds own 97.21% of the company’s stock.

Maximus Company Profile

Maximus, Inc (NYSE: MMS) is a global provider of government services focused on delivering health and human services programs. The company partners with federal, state, and local agencies to administer and manage programs that support individuals and families across various stages of life. Key service areas include eligibility determination and enrollment services for Medicaid, Medicare, Children’s Health Insurance Program (CHIP) and other public assistance programs, as well as call center operations, case management and program integrity solutions.